{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:02:30Z","timestamp":1787666550574,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":1096,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5T32DA007233-37"],"award-info":[{"award-number":["5T32DA007233-37"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jpainsymman.2021.09.014","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T20:44:58Z","timestamp":1634330698000},"page":"179-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Has Declining Opioid Dispensing to Cancer Patients Been Tailored to Risk of Opioid Harms?"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7459-9798","authenticated-orcid":false,"given":"Tarlise N.","family":"Townsend","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talya","family":"Salz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Haffajee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.V.","family":"Caram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiko","family":"Chino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.B.","family":"Bohnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0001","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/1468-0009.12436","article-title":"The association of state opioid misuse prevention policies with patient- and provider-related outcomes: a scoping review","volume":"98","author":"Mauri","year":"2020","journal-title":"Milbank Q"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0002","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1377\/hlthaff.2016.0448","article-title":"Mandatory provider review and pain clinic laws reduce the amounts of opioids prescribed and overdose death rates","volume":"35","author":"Dowell","year":"2016","journal-title":"Health Affairs"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0003","first-page":"15359","article-title":"Laws limiting prescribing and dispensing of opioids in the United States, 1989-2019","author":"Davis","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0004","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/jamasurg.2019.2104","article-title":"When a vital sign leads a country astray\u2014the opioid epidemic","volume":"154","author":"Chidgey","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0005","first-page":"697","article-title":"Vital signs: changes in opioid prescribing in the United States, 2006\u20132015","volume":"66","author":"Guy","year":"2017"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0006","doi-asserted-by":"crossref","DOI":"10.1200\/JOP.19.00081","article-title":"Opioids and cancer pain: patient needs and access challenges","author":"Page","year":"2019","journal-title":"JOP"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0007","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jamaoncol.2020.2211","article-title":"Changes in opioid prescribing patterns among generalists and oncologists for Medicare part D beneficiaries from 2013 to 2017","volume":"6","author":"Agarwal","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0008","doi-asserted-by":"crossref","unstructured":"Chou R, Wagner J, Ahmed AY, Blazina I, Brodt E, Buckley DI, et al. Treatments for acute pain: A systematic review [Internet]. Agency for Healthcare Research and Quality (AHRQ); 2020 Dec [Accessed January 26, 2021]. Available from: https:\/\/effectivehealthcare.ahrq.gov\/products\/treatments-acute-pain\/research","DOI":"10.23970\/AHRQEPCCER240"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0009","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0010","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1200\/JCO.2014.56.0383","article-title":"Quality of cancer pain management: An update of a systematic review of undertreatment of patients with cancer","volume":"32","author":"Greco","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0011","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1200\/JCO.21.00476","article-title":"US trends in opioid access among patients with poor prognosis cancer near the end-of-life","volume":"39","author":"Enzinger","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0012","doi-asserted-by":"crossref","first-page":"392","DOI":"10.6004\/jnccn.2019.7379","article-title":"Bridging the gap among clinical practice guidelines for pain management in cancer and sickle cell disease","volume":"18","author":"Schatz","year":"2020","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0013","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.2016.68.5206","article-title":"Management of chronic pain in survivors of adult cancers","volume":"34","author":"Paice","year":"2016","journal-title":"Am Soc Clin Oncol Clin Practice Guideline"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0014","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.genhosppsych.2019.04.016","article-title":"A systematic review of substance use and substance use disorders in patients with cancer","volume":"60","author":"Yusufov","year":"2019","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0015","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s40140-020-00415-4","article-title":"Alcohol, tobacco, and substance use and association with opioid use disorder in patients with non-malignant and cancer pain: a review","volume":"10","author":"Dev","year":"2020","journal-title":"Curr Anesthesiol Rep"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0016","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0017","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","article-title":"Update on prevalence of pain in patients with cancer: systematic review and Meta-Analysis","volume":"51","author":"van den Beuken-van Everdingen","year":"2016","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0018","unstructured":"University of Michigan Institute for Healthcare Policy and Innovation. OptumInsight data seminar. 2016."},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0019","doi-asserted-by":"crossref","first-page":"k2833","DOI":"10.1136\/bmj.k2833","article-title":"Trends in opioid use in commercially insured and Medicare advantage populations in 2007-16: retrospective cohort study","volume":"362","author":"Jeffery","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0020","unstructured":"NYU Langone Health. Getting started with the institutional review board submission process. 2020. Available at: https:\/\/med.nyu.edu\/research\/office-science-research\/clinical-research\/resources-researchers-study-teams\/institutional-review-board-operations\/getting-started-the-irb-submission-process#determine-if-your-project-is-human-subjects-research. Accessed November 29, 2020."},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0021","unstructured":"National Cancer Institute Surveillance, Epidemiology, and end results program. Cancer Stat Facts [Internet]. 2020 [Accessed December 29, 2020]. Available from: https:\/\/seer.cancer.gov\/statfacts\/"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0022","unstructured":"American Cancer Society. Cancer facts & figures 2020. Atlanta; 2020 p. 76."},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0023","unstructured":"National Comprehensive Cancer Network. NCCN guidelines [Internet]. 2020 [Accessed August 31, 2020]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx#site"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0024","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/pds.3247","article-title":"Identification of metastatic cancer in claims data","volume":"21","author":"Nordstrom","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0026","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/jamainternmed.2015.0914","article-title":"Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene","volume":"175","author":"Larochelle","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0027","series-title":"Managing chronic pain in adults with or in recovery from substance use disorders [Internet]","first-page":"128","year":"2011"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0028","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13011-017-0120-7","article-title":"Chronic pain and opioid misuse: a review of reviews","volume":"12","author":"Voon","year":"2017","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0029","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11920-018-0872-4","article-title":"Psychiatry and pain management: at the intersection of chronic pain and mental health","volume":"20","author":"Goesling","year":"2018","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0030","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.jpainsymman.2020.06.015","article-title":"Cancer patients\u2019 perceived difficulties filling opioid prescriptions after receiving outpatient supportive care","volume":"60","author":"Brown","year":"2020","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0031","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0360-3016(92)90768-D","article-title":"Loss of local control with prolongation in radiotherapy","volume":"23","author":"Fowler","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0032","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0360-3016(94)00635-X","article-title":"The adverse effect of treatment prolongation in cervical carcinoma","volume":"32","author":"Petereit","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0033","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2020.0799","article-title":"Incidence of opioid-associated deaths in cancer survivors in the United States, 2006-2016: a population study of the opioid epidemic","author":"Chino","year":"2020","journal-title":"JAMA Oncol [Internet]"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0034","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jama.2021.11013","article-title":"Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids","volume":"326","author":"Agnoli","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0035","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.drugpo.2019.10.001","article-title":"Prescription drug monitoring programs operational characteristics and fatal heroin poisoning","volume":"74","author":"Martins","year":"2019","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0036","unstructured":"Alpert A, Powell D, Pacula RL. Supply-side drug policy in the presence of substitutes: Evidence from the Introduction of Abuse-Deterrent Opiods.:60."},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1162\/rest_a_00755","article-title":"How the reformulation of OxyContin ignited the heroin epidemic","volume":"101","author":"Evans","year":"2019","journal-title":"Rev Econ Stat"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0038","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.addbeh.2017.01.011","article-title":"Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: Evidence from the National Survey of Drug Use and Health","volume":"69","author":"Ali","year":"2017","journal-title":"Addict Behav"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0039","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/hec.3944","article-title":"Adverse health effects of abuse-deterrent opioids: Evidence from the reformulation of OxyContin","volume":"28","author":"Beheshti","year":"2019","journal-title":"Health Econ"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0040","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","article-title":"The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis","volume":"71","author":"Ciccarone","year":"2019","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jpainsymman.2021.09.014_bib0041","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jamaoncol.2019.0042","article-title":"US national trends in opioid-related hospitalizations among patients with cancer","volume":"5","author":"Chua","year":"2019","journal-title":"JAMA Oncol"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392421005595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392421005595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:32:38Z","timestamp":1760131958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392421005595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0885392421005595"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2021.09.014","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Has Declining Opioid Dispensing to Cancer Patients Been Tailored to Risk of Opioid Harms?","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2021.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}